UGT1A128* is associated with greater decrease in serum K⁺ levels following oral intake of procaterol

Norihito YokoeDivision of Respiratory Medicine and Allergology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan,

, MD,

Etsuro YamaguchiDivision of Respiratory Medicine and Allergology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan, Correspondence[email protected]

, MD, PhD,

Masaki NishimuraDivision of Respiratory Medicine and Allergology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan,

, MD,

Hiroyuki TanakaDivision of Respiratory Medicine and Allergology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan,

, MD,

Ayumu TakahashiDivision of Respiratory Medicine and Allergology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan,

, MD, PhD,

Kenji BabaMedical Clinic, Aichi Medical University, Nagakute, Japan,

, MD, PhD,

Masahiko GoshoAdvanced Medical Research Center, Aichi Medical University, Nagakute, Japan, and

, PhD &

Shoshiro OkadaDepartment of Pharmacology, School of Medicine, Aichi Medical University, Nagakute, Japan

, MD, PhD show all

UGT1A128* is associated with greater decrease in serum K⁺ levels following oral intake of procaterol

Supplemental Material.pdf

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

UGT1A1*28 is associated with greater decrease in serum K+ levels following oral intake of procaterol

Supplemental Material.pdf

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

UGT1A128* is associated with greater decrease in serum K⁺ levels following oral intake of procaterol